All
Avastin Regimen Improves Survival in Ovarian Cancer, Including Some HRD-Positive Tumors
June 3rd 2023A progression-free survival benefit was observed in patients with advanced ovarian cancer including those with homologous recombination deficient-positive status who were treated with frontline chemo plus Avastin and Imfinzi followed by maintenance therapy with an Avastin regimen.
Knowing Ones Rights When Working After a Cancer Diagnosis
May 30th 2023As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.
Pausing Endocrine Therapy for Pregnancy May Not Impact Breast Cancer Recurrence Risk
May 30th 2023Women with hormone receptor-positive breast cancer who temporarily interrupted endocrine therapy for pregnancy had a similar recurrence rate to those from a control group, but one expert said that stopping therapy for a short time is still an important decision.